Antioxidant Therapy and Uptake of Human Oxidized LDL by Macrophages
- 17 December 1989
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 570 (1) , 447-448
- https://doi.org/10.1111/j.1749-6632.1989.tb14953.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Malondialdehyde-Altered Protein Occurs in Atheroma of Watanabe Heritable Hyperlipidemic RabbitsScience, 1988
- Modified plasma-derived lipoproteins in human atherosclerotic plaquesAtherosclerosis, 1988
- Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.Proceedings of the National Academy of Sciences, 1987
- Modification of human serum low density lipoprotein by oxidation — Characterization and pathophysiological implicationsChemistry and Physics of Lipids, 1987
- Probucol inhibits oxidative modification of low density lipoprotein.Journal of Clinical Investigation, 1986
- Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.Proceedings of the National Academy of Sciences, 1984
- Cholesterol esterification in macrophages. Stimulation by lipoproteins containing apo B isolated from human aortas.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984
- Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid.Journal of Lipid Research, 1983
- Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol depositionProceedings of the National Academy of Sciences, 1979